ZNTL   $3.15  5.00% Market Closed After Close 3.11 -1.27%

Zentalis Pharmaceuticals Inc
Total Cash 426.38M
totalCashPerShare 5.996
EBITDA -219.22M
Total Debt 44.03M
quickRatio 6.393
currentRatio 6.592
Total Revenue 40.56M
debtToEquity 11.508
Revenue/Share 0.572
ROA -0.24767
ROE -0.42990002
grossProfits
freeCashflow -71.43M
operatingCashflow -166.38M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -5.4377003
profitMargins 0.0
enterpriseValue -173.30M
forwardPE -0.8277311
floatShares 50.96M
sharesOutstanding 71.11M
sharesShort 8.64M
sharesShortPriorMonth 12.28M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.08%
Short Ratio help_outline 2.40%
shortPercentOfFloat 0.25%
impliedSharesOutstanding
bookValue 5.38
Price To Book help_outline 0.55
earningsQuarterlyGrowth
netIncomeToCommon -194.65M
trailingEps -2.64%
forwardEps -3.57%
enterpriseToEbitda 0.79
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 3Q 2024
institutionsCount 201
lastUpdated Oct. 16, 2024, 9:45 p.m.